Epizyme Operating Expenses 2011-2026 | EPZM

Annual Operating Expenses Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	236 M	201 M	150 M	147 M	120 M	135 M	96.5 M	71.6 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
236 M	71.6 M	145 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Graybug Vision GRAY	23.1 M	-	-11.23 %	$ 9.65 M	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.16	-2.61 %	$ 2.54 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.79	-6.17 %	$ 4.31 M	China
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
AbCellera Biologics ABCL	292 M	$ 3.71	-2.88 %	$ 1.11 B	Canada
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 164.05	-1.4 %	$ 8.16 B	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	106 M	$ 8.55	-2.06 %	$ 1.39 B	Britain
BridgeBio Pharma BBIO	304 M	$ 64.53	-1.48 %	$ 12.4 B	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 58.53	-2.03 %	$ 11.2 B	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	47.8 M	-	-	$ 1.2 B	USA
CohBar CWBR	12.4 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	12 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	12 M	-	-4.36 %	$ 27 M	USA
Cabaletta Bio CABA	74.7 M	$ 3.25	-1.52 %	$ 3.8 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Capricor Therapeutics CAPR	49.3 M	$ 25.84	-3.8 %	$ 692 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	31.5 M	$ 0.98	-3.92 %	$ 71.9 M	USA
Certara CERT	237 M	$ 7.24	2.7 %	$ 1.16 B	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Entasis Therapeutics Holdings ETTX	52.3 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	104 M	-	7.55 %	$ 38.1 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Coherus BioSciences CHRS	231 M	$ 1.65	-	$ 155 M	USA
Evelo Biosciences EVLO	108 M	-	-14.46 %	$ 27.9 M	USA